A new study from the laboratory of Frederick Alt, PhD, of the Program in Cellular and Molecular Medicine (PCMM) at Boston Children’s Hospital reveals yet another way in which chromatin regulation — changing the configuration of our DNA and its packaging — enables our immune systems to produce its wide-ranging arsenal of antibodies.
In September in the journal Nature, the Alt lab demonstrated how the formation of new loops in chromatin, known as loop extrusion, facilitates the process of V(D)J recombination, allowing bits of genetic code to be mixed and matched to generate new antibodies. The new study, published in Nature on October 30, finds that chromatin looping is also involved in another major method of antibody diversification, known as class switching.
Once V(D)J recombination assembles a specific antibody against a pathogen, class switching adjusts the class of antibody depending on where the infection is located and what kind of response is needed. For example, an infection in the mouth might trigger B cells to make IgA antibodies, found in mucous membranes, instead of IgM antibodies, found mainly in the blood and lymph fluid.
“Until now the mechanism of class switching was totally mysterious,” says Alt.
Together, the papers establish antibody formation as a poster child for the emerging field of chromatin loop extrusion and gene regulation — in which far-flung parts of the genome come together to create a rich repertoire of antibodies. “Loop extrusion contributes to both processes, but in totally different ways,” says Alt.
Related Posts :
Diversifying therapeutic antibodies: From one, come many with potential different uses
A new method for producing antibodies against disease could result in a wider variety of drugs for infectious diseases, immune ...
Sturdier spikes may explain SARS-CoV-2 variants’ faster spread
The fast-spreading U.K., South Africa, and Brazil variants are raising concerns and questions about whether current COVID-19 vaccines will ...
Specialized T cells protect against the deadliest form of malaria
Each year, there are about 230 million cases of malaria globally. Children under the age of 5 are at highest risk of ...
Arthritis drug reduces rates of acute graft-vs-host disease after bone marrow transplant
The immune-suppressing drug abatacept, currently used for rheumatoid arthritis, could make bone marrow transplant safer, report researchers at the Dana-Farber/...